1. Cyclin-dependent kinase inhibitors in head and neck cancer and glioblastoma—backbone or add-on in immune-oncology?
   Christin Riess et al, 2021, Cancer and Metastasis Reviews CrossRef
2. Recent Discovery and Development of Inhibitors that Target CDK9 and Their Therapeutic Indications
   Yuming Zhang et al, 2024, Journal of Medicinal Chemistry CrossRef
3. Harnessing type I interferon-mediated immunity to target malignant brain tumors
   Juhee Lim et al, 2023, Frontiers in Immunology CrossRef